Weight loss peptides (GLP-1 RAs) Originally developed as diabetes treatments, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) exhibit mechanisms of action on metabolism and the pancreas that promote weight loss by:26 Slowing digestion: A longer time to gastric emptying correlates not only with a decreased appetite but also with a milder glucose spike.27 28 A decreased appetite means less desire to consume excess calories, and a less severe spike indicates tighter regulation over a significant weight-gain factor.29 Increasing feelings of fullness: When you do get hungry, a GLP-1 RA can help you reach satiety sooner than you normally would
It downregulates malondialdehyde levels in a rat model of diabetes with cardiac fibrosis, suggesting it might be used to treat diabetes-related cardiac fibrosis [69]
Together, these tables provide a complete overview of how the hypothalamus regulates both divisions of the pituitary gland through different mechanismsdirect neural connections for the posterior pituitary and releasing/inhibiting hormones delivered through the portal blood system for the anterior pituitaryto control diverse physiological processes including reproduction, growth, metabolism, stress response, lactation, and fluid balance
doi: 10.1002/ana.25751 130
Most patients spend years dismissing symptoms that a simple lab panel would have caught
